1.BIOTECanada<\/b><\/p>\n
BIOTECanada is the national industry association with over 200 members located nation wide, reflecting the diverse nature of Canada\u2019s health, industrial and agricultural biotechnology sectors. In addition to providing significant health benefits for Canadians, the biotechnology industry has quickly become an essential part of the transformation of many traditional cornerstones of the Canadian economy including manufacturing, automotive, energy, aerospace and forestry industries.<\/span><\/p>\n This CEO advisory board serves the needs of small to medium size member companies, most of which do not yet have major products approved or on the market. The ECAB addresses issues affecting smaller companies and facilitates the development of BIOTECanada\u2019s programs and policy positions to enhance the development of these companies.<\/span><\/p>\n POLICY MATTERS<\/span><\/p>\n VACCINE WHITE PAPER SERIES<\/span><\/p>\n INDUSTRY DATA<\/span><\/p>\n BIOTECHNOLOGY ECOSYSTEM<\/span><\/p>\n FINANCING<\/span><\/p>\n HEALTH<\/span><\/p>\n AGRICULTURE & INDUSTRIAL<\/span><\/p>\n Contact no: <\/b>+1 613-230-5585<\/span><\/p>\n Address:<\/b>1 Nicholas St #600, Ottawa, ON K1N 5X6, Canada<\/span><\/p>\n Website: <\/b>http:\/\/www.biotech.ca\/<\/span><\/a><\/p>\n For more: Top Mining Companies in Canada<\/a><\/p>\n 2.Akshaya Bio Inc.<\/b><\/p>\n Akshaya Bio Inc. (Akshaya) is a privately held development stage biotechnology company located in Edmonton, Alberta, Canada.<\/span><\/p>\n Akshaya develops innovative therapeutics for infectious diseases and cancer. Akshaya’s proprietary Chimigen\u00ae Platform Technology uses dendritic cell receptor-targeted chimeric molecules to develop a portfolio of biotherapeutic agents to meet major unmet medical needs such as treatments for chronic hepatitis B and hepatitis C virus infections, avian and swine influenza, alphavirus infections, malaria, HIV and cancer.<\/span><\/p>\n The Chimigen\u00ae Platform is used to produce Dendritic Cell Receptor-targeted Chimeric Molecules which have therapeutic as well as prophylactic applications. The vaccines produced in insect cells incorporate functional elements of both antigens and antibody. They mimic endogenous antigen presentation and elicit balanced cellular and humoral immune responses.<\/span><\/p>\n Technology<\/b><\/p>\n Chimigen\u00ae Technology Platform<\/span><\/p>\n Akshaya’s proprietary Chimigen\u00ae Platform is a unique, versatile and highly adaptable platform which can be used for developing immunotherapeutic agents and for cell-specific targeted delivery of biologicals including siRNA. Akshaya utilizes the Chimigen\u00ae Platform to develop therapeutic vaccines for patients with chronic viral infections as well as prophylactic vaccines to prevent infections.<\/span><\/p>\n The Chimigen\u00ae Platform is a flexible platform vaccine technology designed to elicit both humoral and cellular immune responses in hosts. Chimigen\u00ae Vaccines are recombinant proteins that have selected antigens fused to the Fc fragment of a murine monoclonal antibody through proprietary peptide linkers. Chimigen\u00ae Vaccines contain two domains, the Target Binding Domain (TBD) and the Immune Response Domain (IRD). This approach allows for efficient substitution of a desired antigen (the IRD) onto the TBD backbone, permitting production of highly desirable and effective multivalent vaccines.<\/span><\/p>\n Contact no:<\/b> +1 780-431-9503<\/span><\/p>\n Address<\/b>: 8223 Roper Rd NW, Edmonton, AB T6E 6S4, Canada<\/span><\/p>\n Website<\/b>: http:\/\/www.akshayabio.com\/<\/strong><\/a><\/span><\/p>\n For more: Engineering companies in Canada<\/a><\/p>\n 3.Cyclica Inc.<\/b><\/p>\n Our holistic approach combines computational biophysics and machine learning\u00a0 in an integrated platform to develop safer, more effective medicines for patients.<\/span><\/p>\n Our innovative business model allows us to work with our diverse partners across the globe. Together, we aim to tackle the most prominent challenges in drug discovery and healthcare to create the next generation of life-saving medicines.<\/span><\/p>\n When the world went on lockdown, faced with the unknown, Cyclica refocused and got to work addressing the COVID-19 pandemic. Over the past 6 months, we have actively contributed to the scientific community, and we continue to expand our efforts to tackle one of the greatest healthcare challenges of our time. Learn more about our journey and scientific initiatives to fight COVID.<\/span><\/p>\n Target of Action Elucidation<\/span><\/p>\n Prioritize Lead Candidates<\/span><\/p>\n Enable Drug Repurposing<\/span><\/p>\n Library Screening<\/span><\/p>\n Semi-Generative Exploration<\/span><\/p>\n Fully Generative Exploration<\/span><\/p>\n Contact no:<\/b>1 416-304-9201<\/span><\/p>\n Address:<\/b>207 Queens Quay W Suite 420, Toronto, ON M5J 1A7, Canada<\/span><\/p>\n Website: <\/b>https:\/\/www.cyclicarx.com\/<\/strong><\/a><\/p>\n For more: Real Estate companies in Canada<\/a><\/p>\n 4.Oncolytics Biotech Inc<\/b><\/p>\n Oncolytics Biotech Inc. is developing pelareorep, a safe and well-tolerated intravenously delivered immuno-oncolytic virus (IOV) that kills cancer through a unique mechanism of action with two components, selective tumor lysis and activation of the innate and adaptive immune systems, creating an inflamed phenotype to treat a variety of solid tumors and hematological malignancies.<\/span><\/p>\n Oncolytics Biotech Inc. is developing an intravenously delivered immuno-oncolytic virus called pelareorep, for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that: 1) induces selective tumor lysis, and 2) promotes an inflamed tumor phenotype through innate and adaptive immune responses. Our clinical development plan is based on these two components of the mechanism of action, with a focus on obtaining regulatory approval as soon as possible.<\/span><\/p>\n TECHNOLOGY<\/b><\/p>\n CLINICAL TRIALS<\/span><\/p>\n MEDIA<\/span><\/p>\n INVESTORS<\/span><\/p>\n OVERVIEW<\/span><\/p>\n PRESS RELEASES<\/span><\/p>\n EVENTS & PRESENTATIONS<\/span><\/p>\n STOCK INFORMATION<\/span><\/p>\n FILINGS & FINANCIALS<\/span><\/p>\n CORPORATE GOVERNANCE<\/span><\/p>\n Contact no:<\/b>+1 403-670-7377<\/span><\/p>\n Address:<\/b>1167 Kensington Crescent NW, Calgary, AB T2N 1X7, Canada<\/span><\/p>\n Website: <\/b>https:\/\/www.oncolyticsbiotech.com\/<\/strong><\/a><\/p>\n For more: Paint companies in Canada, Paint companies near me<\/a><\/p>\n 5.SANOFI BIOGENIUS CANADA<\/b><\/p>\n This year, Sanofi Biogenius Canada is happening virtually! We\u2019re building a fantastic new online platform \u2013 you can choose to compete individually or in a group of two \u2013 to bring all SBC competitors together in one space for the first time, whether you\u2019re at school or at home. Innovation knows no boundaries!<\/span><\/p>\n At Sanofi Biogenius Canada, we believe that all Canadian youth deserve access to hands-on STEM learning and instruction to embrace scientific discovery. It is a crucial part of helping our young innovators build the skills they need for future success.<\/span><\/p>\n The Sanofi Biogenius Grant program exists to provide Canadian students with access to scientific equipment and learning resources to create opportunities for hands-on learning in school \u2013 stimulating curiosity and motivating students to explore STEM.<\/span><\/p>\n We\u2019re helping light the spark of inspiration for high school students across Canada, supporting science exploration in the classroom and beyond, because research knows no boundaries.<\/span><\/p>\n Contact no<\/b>: +1 519-433-7841<\/span><\/p>\n Address<\/b>:100 Collip Cir, London, ON N6G 4X8, Canada<\/span><\/p>\n Website<\/b>: https:\/\/biogenius.ca\/<\/strong><\/a><\/span><\/p>\n For more: Insurance Companies In Montreal<\/a><\/p>\n 6.JLABS @ Toronto<\/b><\/p>\n In May 2016, Toronto became the sixth JLABS site and the first to be located outside the U.S. Situated right in downtown Toronto within the MaRS Discovery District, North America\u2019s largest urban innovation hub, JLABS @ Toronto is surrounded by researchers, investors, government and entrepreneurs, all supporting the advancement of healthcare innovation.<\/span><\/p>\n JLABS @ Toronto supports over 50 resident companies and has over 20 alumni companies within its network. Companies advancing consumer products, therapeutics, medical devices, health tech and cross sector focuses make up the vibrant JLABS @ Toronto resident and alumni community. The current resident demographic reflects the region\u2019s leadership in the fields of artificial intelligence, regenerative medicine, oncology and vision care.<\/span><\/p>\n Johnson & Johnson Innovation Areas of interest<\/span><\/p>\n Our focus is on supporting emerging pharmaceutical, medical device, consumer and digital health companies through the tenuous time between early discovery and having the necessary resources to move a product through the path to commercialization. We give companies every tangible advantage to succeed, providing access to core research facilities hosting specialized capital equipment, educational programs, operational capabilities and a community of like-minded entrepreneurs.<\/span><\/p>\n Contact no:<\/b>1 647-243-5200<\/span><\/p>\n Address<\/b>:MaRS Centre, West Tower, 661 University Ave Suite 1300, Toronto, ON M5G 0B7, Canada<\/span><\/p>\n Website<\/b>: https:\/\/jlabs.jnjinnovation.com\/locations\/jlabs-toronto<\/a><\/span><\/p>\n For more: Construction Companies In Montreal, Construction Companies near me<\/a><\/p>\n 7.AbCellera<\/b><\/p>\n We partner with drug developers of all sizes to push therapeutic programs forward and fight disease. When you need to move quickly and tackle the toughest problems in drug development, we’ve got your back. We\u2019ll work closely with your team and do what it takes to deliver.<\/span><\/p>\n We believe advancing science enhances lives, and it all starts with great collaborations. We\u2019ve built a place where people feel they are part of something bigger than themselves. A place that exists to push the limits of science and technology, and aims to bring better therapies to patients.<\/span><\/p>\n SOURCES<\/b><\/p>\n IMMUNIZATIONS<\/span><\/p>\n SINGLE-CELL SCREENING<\/span><\/p>\n REPERTOIRE SEQUENCING<\/span><\/p>\n CELIUM<\/span><\/p>\n EXPRESSION & CHARACTERIZATION<\/span><\/p>\n ANTIBODY ENGINEERING<\/span><\/p>\n Contact no:<\/b>+1 604-559-9005<\/span><\/p>\n Address:<\/b>2215 Yukon St, Vancouver, BC V5Y 0A1, Canada<\/span><\/p>\n Websit<\/b>e:https:\/\/www.abcellera.com\/<\/a><\/span><\/p>\n For more: Pharmaceutical Companies In Montreal<\/a><\/p>\n 8.Coastal Genomics<\/b><\/p>\n In August 2020, Coastal Genomics were acquired by Yourgene Health. Yourgene Health is an international molecular diagnostics group which develops and commercialises genetic products and services. The group works in partnership with global leaders in DNA technology to advance diagnostic science.<\/span><\/p>\n Yourgene Health is headquartered in Manchester, UK with offices in Taipei and Singapore, and is listed on the London Stock Exchange\u2019s AIM market under the ticker \u201cYGEN\u201d. For more information, visit www.yourgene-health.com and follow us on LinkedIn and twitter @Yourgene_Health<\/span><\/p>\n The \u201cWhy\u201d behind Coastal Genomics is that good science should not hinge on the fickle nature of manual bench science. We recognize that this is a shared perspective as evidenced by the continued move to automate life science protocols. Techniques that compromise on result quality in exchange for automatability can be a viable option for some workflows. Inevitably though, the demands of new applications that are high value and high throughput in nature come to require high quality input that can only be delivered by golden standard bench techniques.<\/span><\/p>\n LightBench<\/span><\/p>\n NIMBUS Select<\/span><\/p>\n Turnkey Automation of the Process<\/span><\/p>\n Flexible Run Setup<\/span><\/p>\n Pipeline-Level Throughput<\/span><\/p>\n Contact no<\/b>:+1 604-620-1332<\/span><\/p>\n Address<\/b>:4664 Lougheed Hwy #182, Burnaby, BC V5C 5T5, Canada<\/span><\/p>\n Website<\/b>:http:\/\/coastalgenomics.com\/<\/a><\/span><\/p>\n For more: Gaming Companies In Montreal, Gaming Companies near me<\/a><\/p>\n 9.Spindle Biotech Inc.<\/b><\/p>\n Our own experience with RNA synthesis drives our mission. We know RNA synthesis can be slow and expensive, limiting current research and therapies by the speed and labor of creating RNA.<\/span><\/p>\n We have made it our mission to expedite the process of experimenting with RNA by enabling speeds of production never accomplished before.<\/span><\/p>\n Products<\/b><\/p>\n Synthetic Guide RNA<\/span><\/p>\n 96-Well Plate RNA Array<\/span><\/p>\n Contact no:<\/b> +1 226-978-2879<\/span><\/p>\n Address:J<\/b>LABS @ Toronto, 661 University Ave Suite 1300, Toronto, ON M5G 0B7, Canada<\/span><\/p>\n Website:<\/b>https:\/\/spindle.bio\/<\/span><\/a><\/p>\n